Skip Navigation
Menu
ACP Journal Club |15 December 2015

In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo

Fiona Smaill, MSc, FRACP, FRCPC

Article, Author, and Disclosure Information
FULL TEXT
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373:808-22. 26193126

Infectious Disease:

Pulmonology:

In adults with HIV-1 infection, does immediate antiretroviral therapy (ART) reduce severe illness compared with deferred ART? Does isoniazid preventive therapy (IPT) reduce severe illness compared with no IPT?
Randomized, controlled, 2 x 2 factorial trial (TEMPRANO ANRS 12136 trial). ClinicalTrials.gov NCT00495651.
Concealed.*
Unblinded.*
30 months.
9 centers in Abidjan, Ivory Coast.
2076 patients ≥ 18 years of age (median age 35 y, 79% women, median CD4+ count 459...
FULL TEXT
PDF
Not Available
Citations
Citation

Smaill F. In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo. Ann Intern Med. 2015;163:JC5. doi: 10.7326/ACPJC-2015-163-12-005

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2015;163(12):JC5.

DOI: 10.7326/ACPJC-2015-163-12-005

0 Citations

Related Articles
Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
Annals of Internal Medicine; 161 (7): I-22
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial
Annals of Internal Medicine; 161 (7): 461-471
Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy
Annals of Internal Medicine; 161 (6): JC12
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases
Annals of Internal Medicine; 161 (5): 319-327
View MoreView Less

Journal Club
Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy
Annals of Internal Medicine; 161 (6): JC12
Early antiretroviral therapy reduced HIV-1 transmission in serodiscordant couples
Annals of Internal Medicine; 155 (12): JC6-8
In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years
Annals of Internal Medicine; 163 (12): JC4
Guideline: Recommendations are provided for antiretroviral therapies in pregnant women with HIV
Annals of Internal Medicine; 168 (4): JC14
View MoreView Less

Related Topics
HIV
Infectious Disease

HIV, Infectious Disease.

PubMed Articles
Role of Guanidinium-Carboxylate Ion Interaction in Enzyme Inhibition with Implication for Drug Design.
J Phys Chem B 2019.
A pyrophosphate-activated nanochannel inspired by a TRP ion channel.
Chem Commun (Camb) 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×